Ogün Bülbül

6PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOral implantologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2026
Relationship between overall survival and progression-free survival with 18 F-FDG PET/CT metabolic parameters in metastatic breast cancer patients treated with CDK 4/6 inhibitors.

|Mar 28, 2026
Prognostic impact of stage reclassification and N2 subclassification in the ninth edition of TNM classification for non-metastatic lung cancer.

Muhammet Halil Baltacioglu, Demet Nak, Pelin Sahin Oguz

|Aug 22, 2025
Relationship Between [<sup>18</sup>F]FDG PET/CT Texture Analysis and Progression-Free Survival in Patients Diagnosed With Invasive Breast Carcinoma.

Ogün Bülbül, Hande Melike Bülbül, Sibel Göksel

|Feb 07, 2025
Assessment of oral health-related quality of life and oral side effects of radioactive iodine therapy.

Hatice Yemenoglu, Kadriye Peker, Taha Emre Köse

|Oct 19, 2022
Contribution of F-18 fluorodeoxyglucose PET/CT and contrast-enhanced thoracic CT texture analyses to the differentiation of benign and malignant mediastinal lymph nodes.

Ogün Bülbül, Hande Melike Bülbül, Kemal Can Tertemiz

|Oct 18, 2021
Relationships Between DCE-MRI, DWI, and <sup>18</sup>F-FDG PET/CT Parameters with Tumor Grade and Stage in Patients with Head and Neck Squamous Cell Carcinoma

Hande Melike Bülbül, Ogün Bülbül, Sülen Sarıoğlu

Pageof 1

Frequent Collaborators

3 joint publications

Hande Melike Bülbül

2 joint publications

Demet Nak

1 joint publications

Sülen Sarıoğlu

1 joint publications

Özhan Özdoğan